Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...
Nasdaq14d
Myriad Genetics Partners with Hannah Storm to Promote Breast Cancer Risk Awareness Through Genetic Testing
Diaz, President and CEO, Myriad Genetics. “Working with someone of Hannah’s caliber and reach can encourage more women to engage in conversations about their family’s health history and ...
Morningstar14d
Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History
Diaz, President and CEO, Myriad Genetics. “Working with someone of Hannah’s caliber and reach can encourage more women to engage in conversations about their family’s health history and ...
Nasdaq1mon
Myriad Genetics' MyRisk® Hereditary Cancer Test with RiskScore® Recognized as Top Advance in Genomic Medicine
Myriad Genetics, Inc. announced that its MyRisk ... The study, which involved over 130,000 women, demonstrated that RiskScore, which combines a polygenic risk score with traditional risk factors ...